Calcidiol Involvement in Hypertension in Pregnancy
DOI:
https://doi.org/10.61841/5345bj19Keywords:
Vitamin D levels, severe preeclampsia, HELLP syndrome, chronic hypertensionAbstract
This study aims to analyze the relationship of vitamin D levels with severe preeclampsia, chronic hypertension in pregnancy, and HELLP syndrome. A comparative analytic cross-sectional study on 91 participants. Data and blood samples were taken from all pregnant women with significant months of pregnancy diagnosed with severe preeclampsia, chronic hypertension, and HELLP syndrome in educational hospitals. Statistical analysis was performed using Chi Square and one-way ANOVA. From a total of 91 participants, there were 18 HELLP syndromes, 11 chronic hypertensions, and 62 with severe preeclampsia. Demographic data and vitamin D levels among groups were compared, and association analyses were performed. There were no statistically significant differences in age, parity, gestational age, pre-pregnancy BMI, or weight gain during pregnancy between these groups. The levels of SGOT, SGPT, creatinine, and urea in patients with HELLP syndrome were higher, whereas platelet counts were lower than the 2 other groups (p <0.001). No differences or associations were found between vitamin D levels in severe preeclampsia, HELLP syndrome, and chronic hypertension in pregnancy. Vitamin D is involved in the pathogenesis of hypertension in pregnancy, with the finding of lower levels in chronic hypertension compared with levels in severe preeclampsia and HELLP syndrome; however, calcidiol is not a factor that is directly involved in the pathomechanism of hypertension in pregnancy.
Downloads
References
1. Peres G., Mariana M., Cairrão E. Pre-Eclampsia and Eclampsia: An Update on the Pharmacological
Treatment Applied in Portugal. Journal of Cardiovascular Development and Disease. 2018; 5(1): 3. doi:
10.3390/jcdd5010003.
2. Angsar MMD. Karakteristik Ibu Hamil Dengan Preeklampsia Di Rsup Prof. Dr. R. D. Kandou Manado.
Jurnal Kedokteran Klinik. 2017; 1(3).
3. Abildgaard U., Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low
platelet count (HELLP): A review’, European Journal of Obstetrics Gynecology and Reproductive
Biology. Elsevier Ireland Ltd. 2013; 166(2): 117–123. doi: 10.1016/j.ejogrb.
4. Saraswati N., Mardiana. Faktor risiko yang berhubungan dengan kejadian preeklampsia pada ibu hamil (Studi kasus di RSUD Kabupaten Brebes tahun 2014). Unnes Journal of Public Health. 2016; 5(2): 90–99. doi: 10.15294/ujph.v5i2.10106.
5. Wibowo N., et al. Pedoman Nasional Pelayanan Kedokteran: Diagnosis Dan Tata Laksana Pre-Eklamsia. Perkumpulan Obstetri dan Ginekologi Indonesia Himpunan Kedokteran Feto Maternal; 2016.
6. Ullah MI., et al. Does vitamin D deficiency cause hypertension? Current evidence from clinical studies
and potential mechanisms. International Journal of Endocrinology; 2010. doi: 10.1155/2010/579640.
7. Movahedian A., et al. A review of the literature on the association between vitamin D status and the risk
of preeclampsia. Rev Clin Med. 2015; 2(1): 15-18.
8. Singla P., et al. Benefits of Vitamin D Supplementation in Pregnancy for Prevention of Preeclampsia.
International journal of pharmacy and biological science. 2012; 2(3): 144-150.
9. Subki AH., Algethami MR. Prevalence, Risk Factors, and Fetal and Maternal Outcomes of Hypertensive Disorders of Pregnancy: A Retrospective Study in Western Saudi Arabia. Oman Medical Journal. 2018;33(5): 409-415. doi: 10.5001/omj.2018.75.
10. Shiozaki A., Saito S. Risk Factors for Preeclampsia, in Preeclampsia. Comprehensive Gynecology and Obstetrics. singapore: Springer International Publishing. 2018; pp. 3-25. doi: 10.1007/978-981-10-5891-
2.
11. Reslan, O. M. and Khalil, R. A. (2010) ‘Molecular and Vascular Targets in the Pathogenesis and
Management of the Hypertension Associated with Preeclampsia’, Cardiovascular & Hematological
Agents in Medicinal Chemistry, 8, pp. 204–226.
12. Zhou, L. et al. (2018) ‘Combination of Genetic Markers and Age Effectively Facilitates the Identification
of People with High Risk of Preeclampsia in the Han Chinese Population’, BioMed Research
International, pp. 1–10.
13. Michita, R. T. et al. (2018) ‘Genetic Variants in Preeclampsia : Lessons From Studies in Latin-American
Populations’, Frontiers in Physiology, 9(December). doi: 10.3389/fphys.2018.01771.
14. Gold RA., et al. Effect of age , parity , and race on the incidence of pregnancy associated hypertension
and eclampsia in the United States. Pregnancy Hypertension. International Society for the Study of
Hypertension in Pregnancy. 2014; 4(1): 46-53.
15. Cormick, G. et al. (2016) ‘Inter-pregnancy interval and risk of recurrent pre-eclampsia : systematic review
and meta-analysis’, Reproductive Health. Reproductive Health, 13(83), pp. 1–10. doi: 10.1186/s12978-
016-0197-x.
16. Spracklen, C. N. et al. (2017) ‘Physical Activity during Pregnancy and Subsequent Risk of Preeclampsia
and Gestational Hypertension: a Case Control Study’, Matern Child Health J, 20(6), pp. 1193–1202. doi:
10.1007/s10995-016-1919-y.Physical.
17. Gao, Y. et al. (2020) ‘Impact of Physical Activity During Pregnancy on Gestational Hypertension’,
Physical Activity and Health, 4(1), pp. 32–39. doi: https://doi.org/10.5334/paah.49
18. 18 . Xiao J., et al. Is ethnicity a risk factor for developing preeclampsia ? An analysis of the prevalence
of preeclampsia in China. Journal of Human Hypertension. Nature Publishing Group. 2014; (2): 694-698.
19. Hutcheon JA., et al. Pregnancy Weight Gain Before Diagnosis and Risk of Preeclampsia A PopulationBased Cohort Study in Nulliparous Women. Hypertension. 2018; 72: 1-9. doi:
10.1161/HYPERTENSIONAHA.118.10999.
20. Yeasmin S. HELLP Syndrome – A diagnostic dilemma. Northern International Medical College Journal
Review. 2015; 7(1): 87-90.
21. Mulliganthor, Megan L., Felton, Shaili K., Riek, Amy E., Bernal-Mizrachi C. Implications of vitamin D
deficiency in pregnancy and lactation. Am J Obstet Gynecol. 2013; 202(5): 1-17. doi:
10.1016/j.ajog.2009.09.002.
22. Tsiaras WG., Weinstock MA. Factors Influencing Vitamin D Status. Acta Derm Venereol. 2011; 25(2):115–124. doi: 10.2340/00015555-0980.
23. Bikle, D. D. (2015) ‘Vitamin D Metabolism, Mechanism of Action, and Clinical Applications’, Chem Biol, 21(3), pp. 319–329. doi: 10.1016/j.chembiol.2013.12.016.Vitamin.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
